Ozempic and Wegovy Linked to Rare Risk of Sudden Vision Loss

Popular GLP-1 medications including Ozempic and Wegovy have been associated with a slightly increased risk of a rare condition causing sudden, potentially permanent vision loss, according to Rutgers researchers. While the overall risk remains very low, the findings warrant attention given the millions of people worldwide now using these drugs for diabetes management and weight loss. GLP-1 receptor agonists have become increasingly popular in recent years due to their effectiveness in controlling blood sugar and promoting weight reduction. Patients currently taking these medications should remain aware of vision changes and maintain regular eye examinations. Healthcare providers recommend discussing any concerns with their medical team to weigh the benefits and potential risks.